Maternal Mortality Surveillance
Real-time tracking across 44 LGAs | Kano State
Baseline Retrospective (2023-2024)
44 LGAs · KASSEP-based MMR
Prospective Phase 1 (2024-2025)
3,935 deliveries · 23 maternal deaths
Phase 2 (2025-2026) COMPLETED
Data collection complete · 12,228 outcomes recorded
Phase 3 (2026-2027) LIVE
Data collection ongoing · 2,866 outcomes recorded
Data subject to change as submissions continue from 44 LGAs.
State-Level Analysis: Kano State
Overall Progress
Kano State has demonstrated remarkable progress in reducing maternal mortality across all phases. The MMR declined from 937 per 100,000 live births in the baseline period (2023-24) to 584.5 in Phase 1 (2024-25), representing a 37.6% reduction. Phase 2 shows an MMR of 348.6 (62.8% reduction from baseline). Phase 3 is currently at 386.2 (58.8% reduction).
SDG 3.1 Target Progress
The SDG 3.1 target aims for 70 maternal deaths per 100,000 live births by 2030. Kano State has closed 64% of the gap between baseline and the SDG target. The current MMR of 386.2 is 316.2 points above the target.
Senatorial Zone Analysis
Showing data for Phase 3
MMR by Senatorial Zone (Phase 3)
MMR Trend (per 100,000)
Stillbirth Rate (per 1,000)
Phase Comparison Summary
| Indicator | Baseline (2023-24) | Phase 1 (2024-25) | Phase 2 (2025-26) | Phase 3 (2026-27) LIVE |
|---|---|---|---|---|
| MMR (per 100,000) | 937 | 584.5 (95% CI: 389.8–875.6) | 348.6 | 386.2 |
| Stillbirth Rate (per 1,000) | 106 | 70 | 15.6 | 53.4 |
| Live Births | 11,106 | 3,942 | 12,336 | 2,848 |
| Maternal Deaths | 93 | 23 | 43 | 11 |
| Stillbirths | 1,178 | 133 | 192 | 152 |
| Total Deliveries | 11,106 | 3,935 | 16,421 | 16,421 |
| Reduction from Baseline | — | 37.6% | 62.8% | 58.8% |
| SDG Progress | 0% | 67.9% | 67.9% | 63.5% |
Phase 3 LGA Breakdown LIVE
| LGA | Outcomes | Live Births | Stillbirths | Maternal Deaths | MMR | Risk |
|---|---|---|---|---|---|---|
| Kura | 324 | 326 | 0 | 0 | 0.0 | Low |
| Bunkure | 260 | 234 | 31 | 4 | 1,709.4 | High |
| Garun Mallam | 207 | 166 | 41 | 0 | 0.0 | Low |
| Dawakin Kudu | 157 | 156 | 2 | 1 | 641.0 | High |
| Bebeji | 143 | 147 | 2 | 0 | 0.0 | Low |
| Dawakin Tofa | 143 | 140 | 1 | 4 | 2,857.1 | High |
| Doguwa | 123 | 123 | 1 | 0 | 0.0 | Low |
| Wudil | 121 | 80 | 43 | 0 | 0.0 | Low |
| Tofa | 117 | 115 | 2 | 2 | 1,739.1 | High |
| Rogo | 94 | 94 | 0 | 0 | 0.0 | Low |
| Takai | 93 | 92 | 1 | 0 | 0.0 | Low |
| Tudun Wada | 87 | 117 | 2 | 1 | 854.7 | High |
| Albasu | 85 | 86 | 0 | 1 | 1,162.8 | High |
| Gwarzo | 83 | 150 | 2 | 1 | 666.7 | High |
| Rano | 78 | 78 | 2 | 2 | 2,564.1 | High |
| Gabasawa | 75 | 73 | 2 | 1 | 1,369.9 | High |
| Gaya | 67 | 67 | 0 | 0 | 0.0 | Low |
| Kumbotso | 63 | 64 | 0 | 0 | 0.0 | Low |
| Garko | 62 | 60 | 3 | 2 | 3,333.3 | High |
| Bagwai | 51 | 47 | 5 | 2 | 4,255.3 | High |
| Ajingi | 46 | 46 | 0 | 0 | 0.0 | Low |
| Karaye | 45 | 46 | 1 | 0 | 0.0 | Low |
| Tsanyawa | 37 | 37 | 0 | 0 | 0.0 | Low |
| Tarauni | 37 | 39 | 0 | 0 | 0.0 | Low |
| Dala | 35 | 36 | 2 | 0 | 0.0 | Low |
| Makoda | 27 | 25 | 2 | 0 | 0.0 | Low |
| Ungogo | 26 | 25 | 1 | 2 | 8,000.0 | High |
| Kunchi | 24 | 24 | 0 | 0 | 0.0 | Low |
| Bichi | 24 | 24 | 1 | 1 | 4,166.7 | High |
| Kano Municipal | 19 | 19 | 0 | 0 | 0.0 | Low |
| Rimin Gado | 17 | 19 | 0 | 0 | 0.0 | Low |
| Kabo | 16 | 17 | 0 | 0 | 0.0 | Low |
| Warawa | 15 | 15 | 0 | 0 | 0.0 | Low |
| Nasarawa | 15 | 11 | 4 | 0 | 0.0 | Low |
| Gwale | 12 | 12 | 0 | 0 | 0.0 | Low |
| Gezawa | 12 | 12 | 0 | 0 | 0.0 | Low |
| Madobi | 11 | 10 | 1 | 1 | 10,000.0 | High |
| Fagge | 7 | 8 | 0 | 0 | 0.0 | Low |
| Dambatta | 4 | 4 | 0 | 0 | 0.0 | Low |
| Kibiya | 3 | 3 | 0 | 0 | 0.0 | Low |
| Shanono | 1 | 1 | 0 | 0 | 0.0 | Low |
Key Findings & Recommendations
Key Findings
- 58.8% reduction in MMR from baseline
- Significant disparities exist between senatorial zones
- High-burden LGAs require urgent intervention
- ≥4 ANC visits reduce mortality odds by 89% (AOR=0.11, p<0.001)
- Phase 3 shows continued progress with 58.8% reduction from baseline
Recommendations
- Target high-burden LGAs with intensified community midwifery schemes
- Scale up ANC coverage to ≥4 visits in all LGAs
- Strengthen referral systems in peri-urban and rural areas
- Address zone-specific barriers through tailored interventions
- Accelerate Phase 3 data collection for real-time monitoring